Back to News
Oct 9, 2025 4:00 PM

AstraZeneca Expands Virginia Investment To $4.5 Billion For Cancer, Obesity Drugs

AstraZeneca Plc (NASDAQ:AZN) on Thursday said it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines, including cancer treatments.

This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at Rivanna Futures in Albemarle County, creating approximately 3,600 direct and indirect jobs.

The manufacturing facility is expected to ...